Publication:
Novel quinazoline–chromene hybrids as anticancer agents: Synthesis, biological activity, molecular docking, dynamics and ADME studies

dc.contributor.authorTokalı F. S.
dc.contributor.authorŞenol H.
dc.contributor.authorYetke H. İ.
dc.contributor.authorHacıosmanoğlu E.
dc.contributor.institutionauthorŞENOL, HALIL
dc.contributor.institutionauthorYETKE, HANDE İPEK
dc.contributor.institutionauthorHACIOSMANOĞLU, EBRU
dc.date.accessioned2023-10-05T21:50:20Z
dc.date.available2023-10-05T21:50:20Z
dc.date.issued2023-09-01
dc.identifier.citationTokalı F. S., Şenol H., Yetke H. İ., Hacıosmanoğlu E., "Novel quinazoline–chromene hybrids as anticancer agents: Synthesis, biological activity, molecular docking, dynamics and ADME studies", ARCHIV DER PHARMAZIE, ss.1-16, 2023
dc.identifier.doi10.1002/ardp.202300423
dc.identifier.endpage16
dc.identifier.issn0365-6233
dc.identifier.startpage1
dc.identifier.urihttps://onlinelibrary.wiley.com/doi/10.1002/ardp.202300423
dc.identifier.urihttps://hdl.handle.net/20.500.12645/38570
dc.relation.ispartofARCHIV DER PHARMAZIE
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectEczacılık
dc.subjectMeslek Bilimleri
dc.subjectFarmasötik Kimya
dc.subjectSağlık Bilimleri
dc.subjectPharmacology and Therapeutics
dc.subjectProfessional Sciences
dc.subjectPharmaceutical Chemistry
dc.subjectHealth Sciences
dc.subjectKlinik Tıp (MED)
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectClinical Medicine (MED)
dc.subjectLife Sciences (LIFE)
dc.subjectPHARMACOLOGY & TOXICOLOGY
dc.subjectPHARMACOLOGY & PHARMACY
dc.subjectFarmakoloji
dc.subjectFarmakoloji, Toksikoloji ve Eczacılık (çeşitli)
dc.subjectGenel Farmakoloji, Toksikoloji ve Eczacılık
dc.subjectFarmakoloji (tıbbi)
dc.subjectİlaç Rehberleri
dc.subjectYaşam Bilimleri
dc.subjectPharmacy
dc.subjectPharmacology
dc.subjectPharmacology, Toxicology and Pharmaceutics (miscellaneous)
dc.subjectGeneral Pharmacology, Toxicology and Pharmaceutics
dc.subjectPharmacology (medical)
dc.subjectDrug Guides
dc.subjectLife Sciences
dc.titleNovel quinazoline–chromene hybrids as anticancer agents: Synthesis, biological activity, molecular docking, dynamics and ADME studies
dc.typeArticle
dspace.entity.typePublication
local.avesis.id0bb547a7-089a-45ee-817c-aa94b9c25d99
relation.isAuthorOfPublication1c5c41d3-57c1-4cd3-b92a-b67095184ea9
relation.isAuthorOfPublication657b5cac-96e2-402a-bc8b-3def08da1caf
relation.isAuthorOfPublicationfffb1a2f-62c4-40ee-8fc4-f0f3e62523b9
relation.isAuthorOfPublication.latestForDiscovery1c5c41d3-57c1-4cd3-b92a-b67095184ea9

Files